{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Advair+Diskus+%28combination+of+fluticasone+propionate+and+salmeterol+xinafoate%29", "query": { "intervention": "Advair Diskus (combination of fluticasone propionate and salmeterol xinafoate)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 43, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Advair+Diskus+%28combination+of+fluticasone+propionate+and+salmeterol+xinafoate%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-11T15:07:39.823Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02215122", "title": "Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma", "COPD" ], "interventions": [ { "name": "MGR001", "type": "DRUG" }, { "name": "Advair® Diskus®", "type": "DRUG" }, { "name": "Seretide™ Accuhaler™", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharma UK Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2013-10", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2022-03-07", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02215122" }, { "nct_id": "NCT02024204", "title": "Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Diseases", "Medication Compliance" ], "interventions": [ { "name": "Fluticasone propionate 230mcg for 3 Months", "type": "DRUG" }, { "name": "Current Treatment or no treatment", "type": "DRUG" }, { "name": "Salmeterol 21mcg for 3 Months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2014-04-09", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024204" }, { "nct_id": "NCT00296491", "title": "Study Of Allergic Rhinitis In Patients Who Also Have Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol (FSC)", "type": "DRUG" }, { "name": "montelukast (MON)", "type": "DRUG" }, { "name": "fluticasone propionate (FP)", "type": "DRUG" }, { "name": "placebo nasal", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "placebo capsule", "type": "DRUG" }, { "name": "placebo DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 725, "start_date": "2005-09", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 104, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Scottsdale, Arizona + 88 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00296491" }, { "nct_id": "NCT02175771", "title": "Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "FLOVENT HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "albuterol/salbutamol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 758, "start_date": "2014-07", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Pell City, Alabama + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02175771" }, { "nct_id": "NCT01192178", "title": "Fall Epidemic Viral Pediatric Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FLOVENT™ DISKUS™ 100 mcg BID", "type": "DRUG" }, { "name": "ADVAIR™ DISKUS™ 100/50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 339, "start_date": "2010-08", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 38, "location_summary": "Tucson, Arizona • Bakersfield, California • Fresno, California + 33 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01192178" }, { "nct_id": "NCT02061280", "title": "Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol 250/50 Dry Powder Inhaler", "type": "DRUG" }, { "name": "fluticasone/salmeterol 100/50 Dry Powder Inhaler", "type": "DRUG" }, { "name": "fluticasone 100mcg Dry Powder Inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nemours Children's Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 108, "start_date": "2013-10", "completion_date": "2017-02-17", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 5, "location_summary": "Wilmington, Delaware • Jacksonville, Florida • Orlando, Florida + 2 more", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02061280" }, { "nct_id": "NCT00920959", "title": "Advair Pediatric Once-Daily", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 908, "start_date": "2001-11", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2016-09-15", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 141, "location_summary": "Ozark, Alabama • Tucson, Arizona • Little Rock, Arkansas + 118 more", "locations": [ { "city": "Ozark", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920959" }, { "nct_id": "NCT02649478", "title": "Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone / Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Advair Diskus 100/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1430, "start_date": "2014-08", "completion_date": "2015-11", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 100, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Surprise, Arizona + 75 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02649478" }, { "nct_id": "NCT00102882", "title": "Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "salmeterol xinafoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 547, "start_date": "2004-10", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2017-02-03", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 86, "location_summary": "Mobile, Alabama • Little Rock, Arkansas • Fresno, California + 70 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00102882" }, { "nct_id": "NCT00521222", "title": "Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone with salmeterol", "type": "DRUG" }, { "name": "Fluticasone HFA", "type": "DRUG" }, { "name": "Ipratropium HFA", "type": "DRUG" }, { "name": "Albuterol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2007-06", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2023-04-21", "last_synced_at": "2026-10-11T15:07:39.823Z", "location_count": 3, "location_summary": "Hackensack, New Jersey • New York, New York", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521222" } ] }